Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer-Reference-Cited by-同舟云学术

Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer

Published:2006-01-25 Issue:1 Volume:939 Page:425-435
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

BACHURIN S.,BUKATINA E.,LERMONTOVA N.,TKACHENKO S.,AFANASIEV A.,GRIGORIEV V.,GRIGORIEVA I.,IVANOV YU.,SABLIN S.,ZEFIROV N.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2001.tb03654.x/fullpdf

Reference23 articles.

1. Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease;Harkany;Proc. Neuropsychopharmacol. Biol. Psychiatry,1999

2. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons;Mattson;Neuron,1990

3. Neuron-specific and state-specific differences in calcium homeostasis regulate the generation and degeneration of neuronal architecture;Mills;Neuron,1990

4. Role of Ca2+ and other second messengers in excitatory amino acid receptor mediated neurodegeneration: clinical perspectives;Schoesboe;Clin. Neurosci.,1997

5. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia;Muller;Pharmachopsychiatry,1995

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition;Biomedicine & Pharmacotherapy;2024-09

2. Potent and reversible open-channel blocker of NMDA receptor derived from dizocilpine with enhanced membrane-to-channel inhibition;2024-04-17

3. Effects of small molecules on neurogenesis: Neuronal proliferation and differentiation;Acta Pharmaceutica Sinica B;2024-01

4. Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview;Life Sciences;2023-12

5. Advances in the discovery of heterocyclic-based drugs against Alzheimer’s disease;Expert Opinion on Drug Discovery;2023-10-06